Danazol fails to increase factor VIII or IX levels in a double‐blind crossover study of patients with haemophilia A and B
article
OA: closed
CC0
⤵ 3 in-corpus citations
AI-generated summary
Danazol treatment did not alter factor VIII or IX levels in patients with hemophilia A or B, and in some patients, it increased bleeding and shortened lysis times.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Twenty-one patients, 14 with haemophilia A and seven with haemophilia B, completed a double-blind crossover study to evaluate the effects of danazol on factor VIII and factor IX levels. Clotting and immunoradiometric assays were used to measure factor levels at baseline, 2 weeks and 8 weeks on both danazol and placebo. Fibrinogen, plasminogen and activated partial thromboplastin time were measured on all patients during placebo and danazol treatment. Although plasminogen levels rose significantly (P less than 0.01) and fibrinogen decreased (P less than 0.01), factor VIII and IX levels did not change. While on danazol, three patients had increased bleeding and shortened euglobulin lysis times compared to their baseline levels. We conclude that danazol does not raise factor VIII or IX levels and increases bleeding in some patients.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex
- Benefits of danazol treatment in patients with hemophilia A (classic hemophilia) via openalex
- Benefits of Danazol Treatment in Patients With Hemophilia A (Classic Hemophilia) via openalex
- Effect of danazol on coagulation parameters and bleeding in hemophilia via openalex
- Effect of Danazol on Coagulation Parameters and Bleeding in Hemophilia via openalex
- Poor response to danazol in hemophilia via openalex
- doi:10.1172/jci109209 via openalex
- doi:10.1111/j.1365-2141.1972.tb05701.x via openalex
- doi:10.1056/nejm198408303110913 via openalex
- doi:10.1055/s-0039-1689482 via openalex
- doi:10.1159/000205234 via openalex
- doi:10.2307/2283756 via openalex
- doi:10.1056/nejm198401053100106 via openalex
- doi:10.1056/nejm197612232952602 via openalex
- doi:10.1016/0049-3848(84)90165-8 via openalex
- doi:10.1016/0049-3848(81)90052-9 via openalex
- doi:10.1182/blood.v62.5.1027.1027 via openalex
- doi:10.1056/nejm198306093082305 via openalex
- W101550465 via openalex
- doi:10.1055/s-0038-1651378 via openalex
Cited by (3)
Source provenance
- openalex
- last seen: 2026-05-11T03:21:38.852240+00:00
- unpaywall
- last seen: 2026-08-25T06:41:39.333708+00:00
License: CC0
· commercial use OK